Cancer Immunology Research
-
Publication Venue For
- Abstract A092: Surpassing the emerging immune-checkpoint inhibitor market. 4:A092-A092. 2016
- Abstract A157: Oncolytic poliovirus mediated immune events. 4:A157-A157. 2016
- Abstract B140: Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: Analysis of data on the current use of HD IL-2. 4:B140-B140. 2016
- Estrogens regulate tumor associated tissue eosinophilia to promote tumor growth 2022
- APOBEC mutagenesis as a driver of tumor evolution by promoting tumor recurrence and modulating tumor-immune system interactions in a syngeneic murine model of breast cancer. 2021
- The effects of CCL3 on dendritic cell migration and immune cell activation. 2020
- Trastuzumab therapy suppresses HER2+breast tumor growth through inducing ADCP by tumor-associated macrophages and synergizes with CD47 checkpoint blockade. 2020
- Blocking proinvasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NAS). 2020
- Dormant breast tumor cells avoid the adaptive immune system through regulation of the immune and tumor microenvironment. 2020
- Impact of CaMKK2 inhibition in tumor-associated myeloid cells on CD8+cytotoxic T-cell recruitment into mammary tumors. 2020
- Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. 2020
- PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. 2020
- Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity. 2020
- Abstract A22: Augmentation of a novel adenoviral vaccine strategy by checkpoint inhibitors 2018
- Abstract A79: Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of antigen-presenting cells and tumor antigen-specific CTLs 2018
- Abstract B66: Targeted activation of innate immune adaptors MAVS and STING promotes antitumor responses in colorectal cancer models 2018
- Abstract A38: Checkpoint blockade elicits unique T cell expansion to promote tumor regression 2017
- Abstract B04: Intralesional vaccination with Ad-MAVS alters the immunosuppressive tumor microenvironment and elicits robust anti-tumor immunity in non-immunogenic cancers 2017
- Abstract B36: Modulating the tumor microenvironment to enhance cancer immunotherapy by inducing phosphatidylserine expression on the tumor surface 2017
- Abstract A032: Using oncolytic polio expressing tumor as a cancer vaccine 2016
- Abstract IA32: Commensal microorganisms and polymorphic mucosal surfaces determine the evolution of distal metastatic tumors 2016